ABACHAI - Safety and efficacy of abatacept (s.c.) in patients with CTLA4 insufficiency or LRBA deficiency, a phase II clinical trial

Study limitation reported by the research below: “Single-arm open-label design means efficacy comparisons are observational; placebo or active comparator data are absent.”